-+ 0.00%
-+ 0.00%
-+ 0.00%

ALX Oncology’s Jeff Knight, chief development and operating officer, files Form 3 ownership statement

PUBT·04/17/2026 20:10:48
Listen to the news
ALX Oncology’s Jeff Knight, chief development and operating officer, files Form 3 ownership statement
  • ALX Oncology filed an initial beneficial ownership statement for Jeff E. Knight in his role as chief development and operating officer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-161540), on April 17, 2026, and is solely responsible for the information contained therein.